Intestinal Organoids

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 6, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Digestive System DiseasesInflammatory Bowel Disease, Ulcerative Colitis TypeCrohn Disease
Interventions
PROCEDURE

additional biopsies

"After Verification of eligibility criteria, patient information and consent, digestive biopsies performed for the study are in addition to those performed for the patient's follow-up:~* 6 biopsies are taken on average in clinical routine~* 4 additional biopsies are necessary to obtain a sufficient number of amplifiable stem cells The samples will be sent within one hour to the Biological Resource Center of the University Hospital of Rennes at room temperature in a tube containing isotonic saline. (CRB).~Biopsies will be then prepared by isolating intestinal crypts and cultured on a 3D matrix gel (matrigel) with added growth factors reproducing the niche environment of intestinal stem cells, which favors the development of an intestinal epithelium. After intestinal differentiation, organoids will be used for research such as molecular screening, assessment of the effects of intestinal stress and healing."

Trial Locations (1)

Unknown

RECRUITING

CHU de RENNES-Service des Maladies de l'Appareil Digestif, Rennes

All Listed Sponsors
lead

Rennes University Hospital

OTHER